Author

Yirong Yin

Institution: MSD (China) Investment Co., Ltd. (China)

Observed institutions: Affiliated Hospital of Qingdao University, MSD (China) Investment Co., Ltd. (China)

ORCID: 0009-0000-0860-5862

Observed ORCID: 0009-0000-0860-5862

OpenAlex ID: A5043234196

Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment

2021 · Fang Wang, Shu-Jing An, et al. · Drug Design Development and Therapy · 19

Influencing Factors and Cumulative Risk Analysis of Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma

2021 · Yirong Yin, Xiang Xu, et al. · Frontiers in Oncology · 10

Real-World Treatment Patterns and Unmet Needs of Patients with Locally Advanced Cervical Cancer in Mainland China

2026 · Peng Peng, Jeffrey Chee-Hong Goh, et al. · Oncology and Therapy

Evidence Mapping of Immunotherapy in the Treatment of Locally Advanced Cervical Cancer

2026 · Guangwen Yuan, Jusheng An, et al.

Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey

2026 · Peng Peng, Yirong Yin, et al. · Advances in Therapy

Treatment (Tx) patterns and decision drivers in Chinese patients (pts) with locally advanced cervical cancer (LACC): Results from a national physician survey.

2025 · Peng Peng, Yirong Yin, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 29

H-index: 2

I10-index: 2